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ABSTRACT; 
Background; The annual incidence of tuberculous meningitis (TM) is unknown. TM is a disease that still often 
results in residual sequelae, and has a mortality rate ranging between 15 and 51%. Experience of countries such 
as Pakistan where drug-resistant tuberculosis and TM are prevalent is important. Objective:  To determine the 
frequency of M. Tuberculosis detection in CSF of patients with suspected tuberculous meningitis at a tertiary 
care hospital. Materials and Methods; A total of 95 patients were included in this descriptive study. The 
demographic data like age, sex, height, weight, monthly family income and address of the patients was collected. 
Cases of TBM fulfilling inclusion and exclusion criteria were included in the study. CSF was collected after 
consent, through lumbar puncture (LP) done by the post graduate trainee (author or colleagues) under aseptic 
measures and was sent to the designated hospital laboratory for GeneXpert MTB/Rif assay and report was 
assessed for M. tuberculosis detection. Data was collected and entered in SPSS and analyzed. Results; total of 
95 patients with tuberculous meningitis meeting inclusion criteria of our study were included in this study. Of 
these 95 study cases, 37 (38.9%) were male patients while 58 (61.1%) were female patients. Mean age of our 
study cases was 26.62 ± 5.94 years. Of these 95 study cases, 49 (51.6%) were from rural areas and 46 (48.4%) 
belonged to the urban areas while 62 (65.3%) were from poor families. Seventeen (17.9%) had diabetes and 25 
(26.3%) were having history of hypertension. Mean weight of our study cases was 56.16 ± 10.27 kilograms and 
66 (69.5%) had up to 60 kilograms of weight. Mycobacterium tuberculous was noted in 49 (51.6%) of our study 
cases. Conclusion; High frequency of Mycobacterium tuberculosis was observed in our study in cerebrospinal 
fluid (CSF) of suspected patients of tuberculosis meningitis using genexpert MTB/RIF assay. Mycobacterium 
tuberculosis was significantly associated with age, socioeconomic status, diabetes and hypertension.  
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INTRODUCTION: 
 Tuberculosis (TB) is a devastating illness caused by infection with Mycobacterium tuberculosis (MTB) 
and may involve any system of the body. It is estimated that about 1/3
rd
 of the world’s population is infected 
with tuberculosis (latent)
 1
. In 2014, an estimated 4 million new cases of TB appeared in South East Asia (SEA) 
WHO region which is about 41% of the estimated global TB cases
2
. While in Pakistan, figures for new TB cases 
reached 3,08,417 in 2014
3
. About 10% of patients who have tuberculosis develop tuberculous meningitis (TBM) 
4
, a severe and life threatening central nervous system (CNS) involvement. Approximately a third of patients 
with TBM die soon after presenting to the hospital and many of those surviving are left with severe neurological 
sequel
5
. Prompt diagnosis and treatment of TBM have been shown to be the best predictor of survival
6
. 
However, conventional confirmatory test available for TBM i.e. culture & sensitivity of cerebrospinal fluid 
(CSF) takes 1 to 4 weeks to return a positive test and time is one thing which a patient with TBM is very short 
of. Therefore the clinical value of culture technique is limited to diagnostic confirmation, drug susceptibility 
testing and molecular typing of Mycobacterium tuberculosis. Another most widely applied rapid diagnostic 
technique; Zeihl-Neelson (ZN) microscopic staining of CSF for acid fast bacilli (AFB) has a sensitivity rarely 
exceeding 20% for TBM
7
. With recent advances, more techniques have been evolved e.g. adenosine deaminase 
assay (ADA), nucleic acid amplification techniques(NAAT), Multiplex PCR, GeneXpert MTB/RIF etc., each of 
which has its own pros and cons
8
. Out of these GeneXpert has gained wide popularity. 
 The GeneXpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) is the only fully automated closed-
cartridge real time DNA-based system that is easy to be operated by minimally trained staff and can detect TB in 
less than 2 hours and carries a smaller risk for biohazard and cross-contamination
9
. The Xpert MTB/RIF test was 
approved by the World Health Organization (WHO) in 2010 for the diagnosis of pulmonary TB following 
extensive evaluation projects in six countries led by the Foundation for Innovative New Diagnostics (FIND) 
10
. 
The test has shown sensitivity above 90% for culture positive tuberculosis with high specificity in sputum 
samples, however Xpert MTB/RIF has also been used successfully for extra pulmonary samples including 
cerebrospinal fluid (CSF) 
11
. Since the introduction of the technology, cost per test has significantly dropped
11
 
and recently it is comparable to or even less than the conventional TB confirmatory test  i.e. MTB culture & 
sensitivity. Availability has also increased rapidly in recent years. Currently 42 sites in Pakistan are offering 
GeneXpert
3
. To further betterment, under a project - known as TBXpert - by UNITAID, not only cartridge prices 
were dropped  40% leading to USD 9.98 per cartridge
12
 in 145 countries but also 220 test machines and over a 
million cartridges were purchased in 2013 and with the co-ordination of WHO, installed free of any cost at 
various places in 21 countries of the developing world
13
 including Pakistan. As with the clinical practice, TBM 
cases in research are selected according to some clinical criteria known as composite reference standard (CRS) 
which in previous studies used to be author defined, causing diversity in definition and thus proving to be a 
major stumbling block in comparing various research findings and data. To address this problem, in 2010 at 
South Africa a committee was appointed by 41 international experts in research of TBM, to finalize a consensus 
criteria for tuberculous meningitis for use in future clinical research; i.e. Uniform Tuberculous Meningitis 
Research Case Definition
14
. This is kind of a scoring system (total score = 20) which distributes selected patients 
into three categories i.e. definite, probable and possible; where 'definite' being the ones with positive CSF M. 
tuberculosis culture or positive NAAT or AFB on smear microscopy in context of typical clinical findings and 
other two categories making up the suspected cases. Since the theme of this study is to use GeneXpert in place of 
other diagnostic tools and this that the use of assay in already confirmed cases of TBM can be a burden on 
resources and it is not a comparative study, segregation of certain number of patients into 'definite' category 
seems to reduce the yield of the study. Therefore confirmatory tests e.g. culture will not be included in this study 
and all the selected cases was termed 'suspected' only (score ≥ 6), irrespective of any category.  When same 
approach was followed in part of a study at Vietnam in 2013 under the Oxford University Clinical Research 
Unit, researchers found 59.3% positive results in all the suspected cases
15
 (all categories combined) which were 
no more different than true positive results. According to a meta-analysis of 6 global studies, in an Expert group 
meeting report 2013 by WHO, pooled sensitivity of the assay in CSF was 55.5% when compared against 
composite reference standard (CRS) 
11
. The WHO Expert group recommends that Xpert MTB/RIF should be 
used in preference to conventional microscopy and culture as the initial diagnostic test when testing CSF from 
patients suspected of having TBM
11
. Due to the urgency of diagnosis in suspected TBM cases, a rapid diagnostic 
test like Genexpert will have a great impact on survival. One published study in Pakistan in 2015, on Xpert 
MTB/RIF assay, included only one sample of CSF 
15
.  
Aim of this study was to determine frequency of Mycobacterium tuberculosis detection using 
GeneXpert MTB/RIF assay, in CSF of patients suspected to be suffering from TBM.  
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Materials and Methods 
A total of 95 Patients fulfilling the diagnostic criteria in the Uniform Tuberculous Meningitis Research Case 
Definition (Score ≥ 6) aged less than 50 years of either sex were recruited in this cross-sectional study. Patients 
already on treatment for TBM, recurrent Tuberculous Meningitis, having contraindications to lumbar puncture 
i.e. local infection, bleeding tendencies, papilledema, etc; as evaluated on history and examination were excluded 
from our study. The patients were enrolled from the Inpatient department of medicine, Bahawal Victoria 
Hospital Bahawalpur. The demographic data like age, sex, height, weight, monthly family income and address of 
the patients was collected. Cases of TBM fulfilling inclusion and exclusion criteria were included in the study. 
CSF was collected after consent, through lumbar puncture (LP) done by the post graduate trainee (author or 
colleagues) under aseptic measures and was sent to the designated hospital laboratory for GeneXpert MTB/Rif 
assay and report will assessed for M. tuberculosis detection. Data was entered using software SPSS version 20.  
RESULTS; 
A total of 95 patients with tuberculous meningitis meeting inclusion criteria of our study were included 
in this study. Of these 95 study cases, 37 (38.9%) were male patients while 58 (61.1%) were female patients. 
Mean age of our study cases was 26.62 ± 5.94 years (with minimum age was 19 years while maximum age of 
our study cases was 41 years). Mean of the male patients was 27.35 ± 6.34 years while mean age of the female 
patients was 26.16 ± 5.68 years (p=0.342). Our study results have indicated that majority of our study cases i.e. 
78 (82.1%) were aged up to 30 years. Of these 95 study cases, 49 (51.6%) were from rural areas and 46 (48.4%) 
belonged to the urban areas. Mean monthly family income was 21455.78 ± 5443.23 rupees and 62 (65.3%) were 
from poor families. Seventeen (17.9%) had diabetes and 25 (26.3%) were having history of hypertension. Mean 
weight of our study cases was 56.16 ± 10.27 kilograms and 66 (69.5%) had up to 60 kilograms of weight. 
Mycobacterium tuberculous was noted in 49 (51.6%) of our study cases. 
DISCUSSION; 
Meningitis is the inflammation of meninges that results in many signs and symptoms. A wide variety of causes 
include infectious and noninfectious are important. Among the infectious causes of meningitis, some result in 
chronic meningitis that defines as the signs of meningitis last for weeks to months. In this group, fungal and 
tuberculosis (TB) are important causes; and TB meningitis is the commonest cause. Central nervous system 
(CNS) infection due to TB includes three clinical categories: Meningitis, intracranial tuberculoma, and spinal 
involvement. All these forms of CNS infection are encountered frequently in regions where the incidence of TB 
is high. 
A total of 95 patients with tuberculous meningitis meeting inclusion criteria of our study were included 
in this study. Of these 95 study cases, 37 (38.9%) were male patients while 58 (61.1%) were female patients. A 
study conducted by Nabi et al 
16 
from Islamabad reported 55 % female gender preponderance which is in 
compliance with our study results. A study conducted by Saleem et al from Lahore 
 17 
also reported 52 % female 
gender predominance which is in compliance with our study results. A study conducted in Turkey by Yasar et al 
 
18 
reported equal distribution of male and female patients. A study conducted by Sher et al 
 19 
from Karachi has 
also reported 57 % female gender predominance which is close to our study results.  
Mean age of our study cases was 26.62 ± 5.94 years (with minimum age was 19 years while maximum 
age of our study cases was 41 years). Mean of the male patients was 27.35 ± 6.34 years while mean age of the 
female patients was 26.16 ± 5.68 years (p=0.342). Our study results have indicated that majority of our study 
cases i.e. 78 (82.1%) were aged up to 30 years. A study conducted by Nabi et al 
16 
from Islamabad reported 
34.86± 17.54 years mean age of the patients with tuberculous meningitis which is close to our study results. A 
study conducted by Saleem et al 
 17 
from Lahore also reported mean age for male patients were 34±17 years and 
for female patients it was 29.81±17.72 years (p-value=0.398) which is in compliance with that of our study 
results. Fazel et al 
 20  
from Karachi reported 29.65 years mean age of the patients with tuberculous meningitis 
which is close to our study results. A study conducted by Saleem et al from Lahore 
 21 
also reported 34 ± 17 years 
mean age which is similar to our study results. A study conducted in Turkey by Yasar et al 
 18 
reported 32.18 ± 
13.62 years mean age of the patients with tuberculous meningitis which is close to our study results.  
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Of these 95 study cases, 49 (51.6%) were from rural areas and 46 (48.4%) belonged to the urban areas. 
Mean monthly family income was 21455.78 ± 5443.23 rupees and 62 (65.3%) were from poor families. 
Seventeen (17.9%) had diabetes and 25 (26.3%) were having history of hypertension. A study conducted by 
Shore et al 
 22 
from Lahore reported 22 % diabetes which is close to our study results.  
Mycobacterium tuberculous was noted in 49 (51.6%) of our study cases. a study at Vietnam in 2013 
under the Oxford University Clinical Research Unit, researchers found 59.3% positive results in all the suspected 
cases
15
 which is in compliance with our study results. According to a meta-analysis of 6 global studies, in an 
Expert group meeting report 2013 by WHO, pooled sensitivity of the assay in CSF was 55.5% 
11
 which is close 
to our study results. Similar results have been reported by an Indian study conducted by Anuradha et al 
23
.  
CONCLUSION; 
High frequency of Mycobacterium tuberculosis was observed in our study in cerebrospinal fluid (CSF) 
of suspected patients of tuberculosis meningitis using genexpert MTB/RIF assay. Mycobacterium tuberculosis 
was significantly associated with age, socioeconomic status, diabetes and hypertension.  
REFERENCES 
1. World Health Organization. Tuberculosis fact sheet [Internet]. Geneva: World Health Organization; 
2016 Mar [cited 2016 Jun 28]. Available from: http://www.who.int/mediacentre/factsheets/fs104/en/ 
2. World Health Organization, Regional Office for South-East Asia, National TB control programme 
managers. Report of the Regional Meeting Colombo, Sri Lanka, 26-30 October 2015 [Internet]. 
Geneva: World Health Organization; 2016 [cited 2016 Jun 28]. Available from: 
http://www.searo.who.int/tb/documents/sea-tb-363/en/ 
3. World Health Organization. TB country profile of Pakistan [Internet]. Geneva: World Health 
Organization; 2016 Mar 27 [cited 2016 Jun 28]. Available from: 
https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO_HQ_Reports%2FG2%2FPROD%2
FEXT%2FTBCountryProfile&ISO2=PK&LAN=EN&outtype=html 
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of 
tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and 
Monitoring Project. JAMA. 1999 Aug 18;282(7):677-86. 
5. Brancusi F, Farrar J, Heemskerk D. Tuberculous meningitis in adults: a review of a decade of 
developments focusing on prognostic factors for outcome. Future Microbiol. 2012 Sep; 7(9):1101–
1116. 
6. Hsu PC, Yang CC, Ye JJ, Huang PY, Chiang PC, Lee MH. Prognostic factors of tuberculous meningitis 
in adults: a 6-year retrospective study at a tertiary hospital in northern Taiwan. J Microbiol Immunol 
Infect. 2010 Apr;43(2):111-118. 
7. Garg RK. Tuberculosis of the central nervous system. Postgrad Med J. 1999 Mar;75(881):133-140. 
8. Ho J, Marais BJ, Gilbert GL, Ralph AP. Diagnosing tuberculous meningitis - have we made any 
progress? Trop Med Int Health. 2013 Jun;18(6):783-793. 
9. Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new 
rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011 
Sep;6(9):1067-82. 
10. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and 
simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the 
diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update [Internet]. 
Geneva: World Health Organization; 2013 [cited 2016 Jun 28]. Available from: 
http://apps.who.int/iris/handle/10665/112472 
11. World Health Organization, Expert Group Meeting Report. Using the Xpert MTB/RIF assay to detect 
pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children [Internet]. 
Geneva: World Health Organization; 2013 [cited 2016 Jun 28]. Available from: 
http://www.who.int/tb/laboratory/xpert_launchupdate/en/ 
12. Foundation for Innovative New Diagnostics. FIND-negotiated product pricing [Internet]. Geneva: 
Foundation for Innovative New Diagnostics Headquarter; 2011 Apr [cited 2016 Jun 28]. Available 
from: http://www.finddx.org/pricing/ 
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.39, 2017 
 
121 
 
13. World Health Organization. Largest ever roll-out of GeneXpert® rapid TB test machines, in 21 
countries [Internet]. Geneva: World Health Organization; 2013 Sep 10 [cited 2016 Jun 28]. Available 
from: http://www.who.int/tb/features_archive/xpertprojectlaunch/en/ 
14. Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a 
uniform case definition for use in clinical research. Lancet Infect Dis. 2010 Nov;10(11):803-12. 
15. Nhu NT, Heemskerk D, Thu do DA, Chau TT, Mai NT, Nghia HD, et al. Evaluation of GeneXpert 
MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol. 2014 Jan;52(1):226-33. 
16. Nabi S, Khattak S, Badshah M, Rajput HM. Neuroradiological manifestations of tuberculous 
meningitis. Pak J Neurological Sci Apr - Jun 2014;9(2):16-21. 
17. Saleem K, Nasrullah M, Shafiq F. Is CT scan poor predictor of complicated tuberculous meningitis. Pak 
J Med Health Sci. 2015;9(1):26-30. 
18. Yasar KK1, Pehlivanoglu F, Sengoz G. Predictors of mortality in tuberculous meningitis: a multivariate 
analysis of 160 cases. Int J Tuberc Lung Dis. 2010 Oct;14(10):1330-5. 
19. Sher K1, Firdaus, Abbasi A, Bullo N, Kumar S. Stages of tuberculous meningitis: 
a clinicoradiologic analysis. J Coll Physicians Surg Pak. 2013 Jun;23(6):405-8. doi: 
06.2013/JCPSP.405408. 
20. Fazel PA, Makki KU, Haroon H, Soomro IB, Afzal U. Clinical spectrum and outcome of patients with 
Tuberculous Meningitis. Med Channel. 2006;12(4):21-3. 
21. Saleem K, Shah ZH, Siddique K, Abaidullah S, Iqbal M. Predictors of complications of tuberculous 
meningitis. Pak J Med Health Sci. 2011;5(2):292-6. 
22. Shore N, Qutab M, Khawar  S, Majeed Z, Cheema S, Ali I, et al. Tuberculous meningitis: predisposing 
factors in adults admitted in tertiary care hospitals of central Punjab. Pak J Physiol. 2016;12(3):44-6. 
23. Anuradha HK1, Garg RK, Sinha MK, Agarwal A, Verma R, Singh MK, et al. Intracranial tuberculomas 
in patients with tuberculous meningitis: predictors and prognostic significance. Int J Tuberc Lung Dis. 
2011 Feb;15(2):234-9. 
